Skip to content

Makya

Iktos / Iktos

Makya is Iktos’s generative AI SaaS platform for de novo molecular design, combining project objectives, synthesis constraints, and ligand- or structure-based modeling to guide compound selection.

Catalog updated ·

Overview

Makya is a generative AI SaaS platform developed by Iktos for medicinal and computational chemistry teams working on de novo drug design. Its role is to propose molecules against a project’s Target Product Profile and help teams explore, compare, and prioritize candidates. The supplied product page describes ligand- and structure-based design, SAR modeling, and ADMET properties as elements of the project workflow, with multiple objectives considered during molecular generation.

The described workflow starts with importing project data and defining design objectives. Molecular design operations include growing, linking, cyclization, macrocyclization, and fine tuning. Synthesis constraints are incorporated through commercial building blocks and organic reactions, while retrosynthesis is presented as part of the platform. Outputs include generated candidate molecules and associated scores or optimized attributes; the page also describes ligand-based models that generate molecules and their 3D poses from a known active ligand.

For candidate assessment, Makya provides chemical-space exploration, compound insights relative to a reference ligand, and filters using custom scores and 3D interactions. An API enables connections to external models and scoring functions. These are vendor-described capabilities, not independently established performance results. The supplied material does not specify accepted file formats, export schemas, API authentication, or access terms. Its claims about novelty, convergence, and synthetic feasibility should therefore be treated as evaluation questions rather than guarantees for a particular discovery project.

Key Features

  • Molecular generation guided by Target Product Profile constraints and multi-parametric optimization.
  • Synthesis-aware design using commercial building blocks and organic reactions, with retrosynthesis incorporated into the platform.
  • Growing, linking, cyclization, macrocyclization, and fine-tuning operations for molecular design.
  • Ligand- and structure-based modeling, including described ligand-based models that generate molecules and 3D poses from a known active ligand.
  • Chemical-space exploration, reference-ligand comparisons, and candidate filtering by custom scores and 3D interactions.
  • API connections for external models and scoring functions.

Use Cases

  • Intended evaluation: generate candidate series against a project’s Target Product Profile and assess how well the proposals balance competing molecular objectives.
  • Intended evaluation: explore growing, linking, or macrocyclization while checking whether the resulting candidates meet project-specific synthesis constraints.
  • Intended evaluation: use a known active ligand to explore molecular designs and proposed 3D poses, then assess their relevance to the project.
  • Intended evaluation: connect an external scoring model through the API and examine how its scores support candidate filtering and prioritization.

How to Use

  1. Read the official Makya product page to identify the design modes relevant to your project. Use the supplied description as a capability outline, not an input-format specification.
  2. Consult the linked Makya flyer and release factsheet for follow-up product information; their contents were not supplied here.
  3. Request a demonstration through Iktos contact. Ask about access terms, supported imports and exports, data handling, and API requirements before supplying project data.
  4. For an intended evaluation, define your Target Product Profile, reference ligand where relevant, and synthesis constraints. The documented workflow begins with importing project data and setting these objectives.
  5. During the evaluation, explore candidates using the relevant design operations, scores, and 3D-interaction filters. Assess proposed compounds against your own modeling and synthesis criteria rather than assuming vendor claims establish project-specific suitability.

Related resources

AIDDISON Explorer is a hosted drug-discovery platform that generates and ranks molecular candidates against target profiles, design constraints, predicted properties and synthetic feasibility.

Molecular Generation · Drug Discovery

Chemistry42

Platforms

Chemistry42 is a small-molecule discovery platform combining generative design, retrosynthesis, ADMET and selectivity prediction, and physics-based prioritization for hit identification and lead optimization.

Molecular Generation · Drug Discovery

FEgrow

Open Source

FEgrow supports interactive ligand-series construction for free-energy preparation, with documented active-learning examples and Dask-based acceleration for molecular design workflows.

Open source

Molecular Generation · Drug Discovery

REINVENT is a Python molecular-design toolkit that uses generative models, reinforcement learning and transfer learning for configurable small-molecule generation and optimization.

Open sourcePython

Molecular Generation · Drug Discovery

AutoDock Vina

Open Source

AutoDock Vina is an open-source molecular docking and virtual screening program with Vina and AutoDock4.2 scoring, multi-ligand docking, macrocycle support and Python 3 bindings.

Open sourcePython

Drug Discovery

Boltz

Model

Boltz is a biomolecular interaction model family. Boltz-2 provides workflows for complex structure and binding affinity prediction.

Open sourcePython

Drug Discovery

Related guides

Overview

How to Build a Chemistry AI Agent Stack

Design a chemistry AI agent stack by separating language models, orchestration, Skills, MCP interfaces, APIs, libraries and data. Follow proposed molecular and materials workflows, define input/output contracts, and plan permissions, evaluation and reproducible deployment.